Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 16, 2003. The report details changes in directors' interests in the company's Ordinary Shares, specifically regarding transactions involving the GlaxoSmithKline Employee Trust (GSK Trust).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance disclosures regarding share ownership and does not contain financial performance data.
Material Changes
The filing reports two specific transactions involving the transfer of Ordinary Shares from the GSK Trust to participants of the SmithKline Beecham 1991 Share Option Plan:
- April 10, 2003: Transfer of 1,940 Ordinary Shares.
- April 15, 2003: Transfer of 21,156 Ordinary Shares.
These transactions were advised to the company on April 16, 2003.
Management Commentary and Risks
The GSK Trust is identified as a discretionary trust where all current and former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. The filing notes that two directors, Dr. J-P Garnier and Mr. J D Coombe, hold an interest in the shares held within the GSK Trust in the same capacity as other employees. No specific risks, contingencies, or forward-looking guidance are provided in this text.
Investor Verification Points
- Verify the total number of shares transferred under the SmithKline Beecham 1991 Share Option Plan during the reporting period.
- Confirm the specific beneficial ownership status of Directors Dr. J-P Garnier and Mr. J D Coombe relative to the GSK Trust.
- Review the full terms of the SmithKline Beecham 1991 Share Option Plan to understand the vesting and exercise conditions for the transferred shares.